MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1207.59%
Quick Ratio
1207.59%
Cash Ratio
1070.75%
Debt to Asset Ratio
15.88%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Research and development incenti...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, net of current...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
510,052
559,474
628,110
648,325
Prepaid expenses and other current assets
17,765
18,744
19,181
23,231
Research and development incentives receivable
47,419
40,917
35,594
67,263
Total current assets
575,236
619,135
682,885
738,819
Property and equipment, net
4,695
5,734
6,021
6,861
Operating lease right-of-use assets
13,979
14,535
15,886
4,562
Other assets
12,668
12,992
12,805
13,712
Total assets
606,578
652,396
717,597
763,954
Accounts payable
5,662
5,970
9,669
12,653
Accrued expenses and other current liabilities
39,094
40,124
44,354
44,368
Deferred revenue, current portion
2,879
2,795
2,961
12,261
Total current liabilities
47,635
48,889
56,984
69,282
Operating lease liabilities, net of current portion
13,680
13,874
14,096
981
Deferred revenue, net of current portion
34,077
34,340
35,508
74,119
Other long-term liabilities
931
973
1,032
1,093
Total liabilities
96,323
98,076
107,620
145,475
Ordinary shares, including non-voting ordinary shares, 0.01 nominal value 163,361,109 and 159,685,229 shares authorized on june 30, 2026 and december 31, 2025, respectively 69,814,145 and 69,367,896 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
900
899
894
894
Additional paid-in capital
1,525,680
1,519,276
1,512,339
1,500,653
Accumulated other comprehensive loss
-5,416
-5,279
-3,505
-3,471
Accumulated deficit
-1,010,909
-960,576
-899,751
-879,597
Total shareholders' equity
510,255
554,320
609,977
618,479
Total liabilities and shareholders' equity
606,578
652,396
717,597
763,954
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$510,052K (-29.30%↓ Y/Y)Research and developmentincentives receivable$47,419K (-21.95%↓ Y/Y)Prepaid expenses andother current assets$17,765K (-19.46%↓ Y/Y)Total current assets$575,236K (-28.48%↓ Y/Y)Operating leaseright-of-use assets$13,979K (140.77%↑ Y/Y)Other assets$12,668K (-8.26%↓ Y/Y)Property and equipment,net$4,695K (-43.48%↓ Y/Y)Total assets$606,578K (-27.11%↓ Y/Y)Total liabilities andshareholders' equity$606,578K (-27.11%↓ Y/Y)Total shareholders'equity$510,255K (-23.72%↓ Y/Y)Total liabilities$96,323K (-41.00%↓ Y/Y)Accumulated deficit-$1,010,909K (-23.21%↓ Y/Y)Accumulated othercomprehensive loss-$5,416K (-61.05%↓ Y/Y)Additional paid-in capital$1,525,680K (2.27%↑ Y/Y)Total currentliabilities$47,635K (-38.47%↓ Y/Y)Deferred revenue, net ofcurrent portion$34,077K (-58.92%↓ Y/Y)Operating leaseliabilities, net of current...$13,680K (675.07%↑ Y/Y)Other long-termliabilities$931K (-18.26%↓ Y/Y)Ordinary shares,including non-voting...$900K (0.78%↑ Y/Y)Accrued expenses andother current...$39,094K (-12.22%↓ Y/Y)Accounts payable$5,662K (-69.00%↓ Y/Y)Deferred revenue,current portion$2,879K (-80.31%↓ Y/Y)

BICYCLE THERAPEUTICS PLC (BCYC)

BICYCLE THERAPEUTICS PLC (BCYC)